Retatrutide
Triple GIP / GLP-1 / Glucagon Agonist
from$69
Retatrutide is a triple receptor agonist targeting GIP, GLP-1, and glucagon pathways, studied for its role in energy expenditure and metabolic research. Supplied as a verified, single-compound reference material.
SKU: AP-RETA-10MG
- Purity
- ≥ 99% (HPLC verified)
- Format
- Lyophilized powder
- Sizes
- 10 – 60 mg
Research Applications
- Studied for triple GIP/GLP-1/glucagon signaling
- Investigated for energy-expenditure models
- Explored for glucose and lipid metabolism
This product is supplied strictly for in-vitro laboratory research use only. It is not a drug, supplement, or therapeutic, has not been evaluated by the FDA, and is not intended for human or veterinary consumption, injection, or application.
Research Use Only
All content and product information presented on this website is intended for educational and informational purposes only. Products available through Allpointe Bio Research are sold strictly for laboratory research use only — specifically for in-vitro experiments conducted outside the body. These products are not drugs, supplements, or medications, and have not been evaluated or approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease or condition. Under no circumstances should these materials be used for human or animal consumption, injection, or application. Any bodily introduction is a direct violation of federal law.
